Al-Hinai Ahmed S, Al-Abri Mohammed S
Department of Ophthalmology, Sultan Qaboos University Hospital, Oman.
Oman J Ophthalmol. 2011 May;4(2):63-6. doi: 10.4103/0974-620X.83655.
To evaluate the efficacy and safety of half-fluence photodynamic therapy (PDT) in treating chronic central serous chorioretinopathy (CSC) in Omani population.
A Retrospective chart review of all patients with chronic CSC treated with half-fluence PDT from November 2009 to December 2010 was carried out. Recorded parameters included best-corrected visual acuity, findings of clinical examination, results of fluorescein angiography and optical coherence tomography at baseline and during follow-up visits after treatment.
Six eyes (of five Omani patients) with chronic CSC, of at least 9 months duration, were treated with half-fluence PDT. All eyes showed a complete resolution of CSC within 1 month following treatment. Four eyes showed visual improvement and two had unchanged stable vision. No complications from the treatment were noticed during the follow-up visits.
Half-fluence PDT to treat chronic CSC in Omani population is a promising treatment that results in both structural and functional improvement.
评估半剂量光动力疗法（PDT）治疗阿曼人群慢性中心性浆液性脉络膜视网膜病变（CSC）的疗效和安全性。
对2009年11月至2010年12月期间接受半剂量PDT治疗的所有慢性CSC患者进行回顾性病历审查。记录的参数包括最佳矫正视力、临床检查结果、荧光素血管造影结果以及治疗前和治疗后随访期间的光学相干断层扫描结果。
对5名阿曼患者的6只患有至少9个月病程的慢性CSC眼睛进行了半剂量PDT治疗。所有眼睛在治疗后1个月内CSC均完全消退。4只眼睛视力改善，2只眼睛视力稳定未变。随访期间未发现治疗相关并发症。
半剂量PDT治疗阿曼人群慢性CSC是一种有前景的治疗方法，可实现结构和功能的改善。
